Vtesse Inc.   Report issue

For profit Phase 3
Founded: Gaithersburg MD United States (2014)
Status: Acquired by Sucampo (2017) → now Mallinckrodt (2013) (2017)

Organization Overview

First Clinical Trial
2014
NCT01747135
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company